Evolving Evidence Reviews

Evolving Evidence Reviews are designed to help clients develop policies and manage prior authorizations. Evolving Evidence Reviews are useful when a technology moves beyond emerging but the literature is not mature enough for a full Health Technology Assessment. Evolving Evidence Reviews provide a full-text appraisal of clinical studies, systematic reviews, and clinical practice guidelines as they relate to a specific health technology. Evolving Evidence Reviews provide Levels of Support indicated by these types of evidence. They also provide information on regulatory status, payer policies, and Hayes Insights.

neoGEN-Series System (RST-Sanexas) for Treatment of Neuropathic Pain

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the neoGEN-Series system (RST-Sanexas) for the treatment of neuropathic pain for outcomes including pain, function, quality of life, and safety.

ReCell Autologous Skin Cell Suspension (Avita Medical) Combined with Meshed Autograft for Treatment of Acute Thermal Full-Thickness or Mixed-Thickness Burns

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of cell suspensions prepared with the ReCell Autologous Cell Harvesting Device (Avita Medical) combined with meshed autograft for the treatment of acute full-thickness and mixed-thickness thermal burns compared with standard ca…

Computerized Dynamic Posturography for Diagnosis of Vestibular Disorders

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of computerized dynamic posturography (CDP) for diagnosing vestibular disorders in adults with signs and symptoms suggesting vestibular disorder, compared with standard otoneurologic tests. While other Hayes reports have more b…

Barostim Neo System (CVRx Inc.) for Treatment of Heart Failure

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Barostim Neo System (CVRx Inc.) for the treatment of heart failure (HF) to improve quality of life (QOL) and functional outcomes.